Role of granulocyte elastase in ischemia/reperfusion injury of rat liver
Related Experiment Videos
S Kushimoto1, K Okajima, M Uchiba
1Department of Laboratory Medicine, Kumamoto University Medical School, Japan.
Objective:
To investigate the role of granulocyte elastase in ischemia/reperfusion injury of liver, the effect of ONO-5046, a granulocyte elastase inhibitor, was examined in ischemia/reperfusion-induced liver injury in rats.
Design:
Prospective, randomized, controlled study.
Setting:
Research laboratory at a university medical center.
Subjects:
Male Wistar rats, weighing 220 to 280 g.
Interventions:
Animals receiving continuous intravenous infusion of ONO-5046 (50 mg/kg/hr) were subjected to hepatic ischemia/reperfusion. Hepatic damage was evaluated by effects on bile formation capacity, plasma clearance of indocyanine green, and serum aminotransferase concentrations after ischemia/reperfusion.
Measurements And Main Results:
Hepatic dysfunction, observed after 60 mins of ischemia/reperfusion, led to a reduction in bile flow and to a decrease in the plasma clearance of indocyanine green. These indicators of hepatic dysfunction were prevented, to a large extent, by administration of ONO-5046. Serum concentrations of aminotransferases increased after hepatic ischemia/reperfusion, peaking at 12 hrs of reperfusion. Increases in serum concentrations of aminotransferases were significantly inhibited by ONO-5046.
Conclusion:
Granulocyte elastase derived from activated leukocytes may play a critical role in hepatic dysfunction and the subsequent hepatic injury induced by ischemia/reperfusion.